東洋 (4105.TWO)

77.70 -0.10 (-0.13%) 收市：01:30PM CST

東洋

No.3-1, Park Street
3rd Floor Nangang District
Taipei 11503
Taiwan
886 2 2652 5999
https://www.tty.com.tw

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 

高階主管

名稱	頭銜	支付	行使價	出生年份
Yung-Min Chiang	Chief Financial Officer & Chief Auditor	無	無	無
Ms. Shu-Wen Wang	Accounting Officer	無	無	無
Ms. Shu-Fen Huang	Chief Legal & Compliance Officer	無	無	無
Wei-Ying Yin	Director of Public Affairs Department	無	無	無
Mr. Jen-Yang Chang	Chief Human Resource Officer	無	無	無
Ms. Si-Yuan Yang	Senior Vice President	無	無	無
Mr. Allen Chu	Head of Intensive Care Business Unit	無	無	無
Ms. Ching-Lan Hou	General Manager	無	無	無

截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 TWD。

描述

TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally. The company operates through Oncology Business Unit, Health Care Unit, Anti-infection Business Unit, Domestic Cardiovascular and Gastrointestinal Drugs Business Unit, China Medicine Business Unit, and Other segments. It offers oncology drugs under the Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre names for anti-cancer and supplementary treatments. The company also provides anti-infection drugs under the Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax names for anti-infection and flu. In addition, it offers healthcare related drugs under the Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin names for digest system, osteoporosis, and metabolism. Further, the company engages in the selling functional foods; and import and export trading and investment activities. TTY Biopharm Company Limited was incorporated in 1960 and is headquartered in Taipei, Taiwan.

公司管治

截至 無 止，東洋 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。